z-logo
open-access-imgOpen Access
Conformation‐dependent antibody response to Pseudomonas aeruginosa outer membrane proteins induced by immunization in humans
Author(s) -
Lee NaGyong,
Ahn BoYoung,
Jung Sang Bo,
Kim Young Gi,
Kim HyunSu,
Park Wan Je
Publication year - 2000
Publication title -
fems immunology & medical microbiology
Language(s) - English
Resource type - Journals
eISSN - 1574-695X
pISSN - 0928-8244
DOI - 10.1111/j.1574-695x.2000.tb01415.x
Subject(s) - immunization , biology , epitope , antibody , immune system , antigen , microbiology and biotechnology , immunoglobulin g , immunoprecipitation , antibody titer , bacterial outer membrane , virology , humoral immunity , immunology , titer , biochemistry , escherichia coli , gene
Outer membrane proteins (OMPs) of pathogenic bacteria have been used as protective antigens in developing bacterial vaccines. In the present study, we compared the antibody responses to a Pseudomonas aeruginosa OMP vaccine elicited in humans and rabbits by immunization. Immunization with the vaccine induced high titers of serum IgG antibody both in rabbits and humans but reactivities of the induced antibodies with the OMPs were different. The rabbit immune sera recognized most of the OMPs in the vaccine both in immunoblot and immunoprecipitation analyses. In contrast, a great variation in band pattern and intensity was observed among the human immune sera in immunoblot analysis, but not in immunoprecipitation analysis. Denaturation of the OMPs did not affect the binding activity of the rabbit immune sera as determined by ELISA, but substantially reduced those of the human immune sera and anti‐OMP IgG purified from a pooled normal human plasma. These data suggest that antibody response to P. aeruginosa OMPs elicited by immunization in humans is mainly directed against discontinuous or conformation‐dependent epitopes, which should be taken into account in developing vaccines, especially for OMP‐derived synthetic peptides.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here